Bruce Altevogt serves as Vice President for External Medical Engagement in Pfizer Hospital. In this role he oversees the company’s above brand AMR and stewardship strategy, including Pfizer’s ATLAS surveillance program. In addition, his team is responsible for Pfizer’s AMR patient engagement work, its Medical diagnostics work, and other initiatives in support of its conditionally authorized COVID therapeutic. He serves on numerous external advisory boards and working groups, including serving as a founding board member of the AMR Industry Alliance. Bruce received a PhD in neuroscience from Harvard University and prior to joining Pfizer worked as senior program officer at the U.S. National Academy of Sciences.